• - Clinical trials in peritoneal metastases, Patients, Specialists

    HIPEC improves survival in advanced ovarian cancer patients

    A Dutch study published in the New England Journal of Medicine has shown a survival benefit of 12 months in ovarian cancer patients when treated with HIPEC.

    Read more
  • - Clinical trials in peritoneal metastases, Specialists

    CAIRO6 Randomised Controlled Trial

    The CAIRO6 RCT in The Netherlands aims to investigate the value of systemic therapy to CRS and HIPEC in colorectal peritoneal metastases

    Read more
  • - Clinical trials in peritoneal metastases, Uncategorized

    The OVHIPEC trial for ovarian cancer – the Netherlands

    The OVHIPEC-trial in the Netherlands compares interval debulking plus or minus the perfusion of the abdomen with chemotherapy under hyperthermic conditions during surgery (OVHIPEC).

    Read more
  • Clinical trials in peritoneal metastases

    Adjuvant HIPEC in patients with high-risk colon cancer

    This trial from the Netherlands aims to determine the effectiveness of adjuvant HIPEC preceding routine adjuvant systemic therapy using i.p. oxaliplatin with concomitant i.v. 5-FU/LV following a curative resection of a T4 or intra-abdominally perforated colon cancer in preventing the development of PC in comparison to standard adjuvant systemic treatment alone.

    Read more
  • Clinical trials in peritoneal metastases

    Fase II clinical trial investigating HIPEC in ovarian cancer – Brasil

    A phase II open label, single arm clinical trial on safety and efficacy exploring a short-course high-dose regimen of intra-operative HIPEC as upfront therapy for patients with advanced Epithelial Ovarian Cancer (EOC) from Brasil

    Read more
  • Clinical trials in peritoneal metastases

    Trial information

    We welcome short descriptions of ongoing trials world-wide. Information may be sent to: info@HIPEC.com

    Read more